| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/04/2002 | US20020086331 Crystal structure of worm NitFhit reveals that a Nit tetramer binds two Fhit dimers |
| 07/04/2002 | US20020086330 Nucleotide sequences coding polypeptide for use in diagnosis, prevention and treatment of preferential urogenital disorders |
| 07/04/2002 | US20020086328 Gdu, a novel signalling protein |
| 07/04/2002 | US20020086321 Myeloid cell leukemia associated gene MCL-1 |
| 07/04/2002 | US20020086320 Detecting prostate cancer gene in test sample; obtain nucleotide sequence sample, incubate with probe, detect signal for from probes bound to target sequences |
| 07/04/2002 | US20020086316 Reagents and methods useful for detecting diseases of the prostate |
| 07/04/2002 | US20020086314 Nucleotide sequences coding polypeptides for use in the treatment of cancer |
| 07/04/2002 | US20020086312 Screening for modulator of receptor binding activity; obtain cells, incubate with modulator, monitor cell response |
| 07/04/2002 | US20020086311 Detecting mmutation in gene for enzymatic polypeptide; obtain nucleotide squences sample, amplify sequences, detect duplication of nucleotide sequences, the presence of the duplication indicates preferential genetic disorder |
| 07/04/2002 | US20020086308 Ribosome crystaline structure; for use in killing or prevention of propagation of target organism |
| 07/04/2002 | US20020086305 Human c-Maf compositions and methods of use thereof |
| 07/04/2002 | US20020086304 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 07/04/2002 | US20020086303 Nucleotide sequences coding polypeptides for use in the diangosis and treatment of tumors |
| 07/04/2002 | US20020086300 Nucleottide sequences coding preferential proteins for use in food and pharmacology |
| 07/04/2002 | US20020086298 DNA encoding inward rectifier, G-protein activated, mammalian, potassium KGA channel and uses thereof |
| 07/04/2002 | US20020086297 Gene alteration in the gene for the Gbeta3-subunit of the human G protein |
| 07/04/2002 | US20020086285 Variant of LAV viruses |
| 07/04/2002 | US20020086283 Immunogen |
| 07/04/2002 | US20020086276 Immunotherapeutic methods for extracorporeal modulation of CD36 and its ligands |
| 07/04/2002 | US20020086037 For use in therapy of bacterial infections, cancer; in vaccines |
| 07/04/2002 | US20020086036 Therapy of hyperhidrosis (excessive sweating) in a mammal, by locally administering a drug particle to an affected skin area without using a needle |
| 07/04/2002 | US20020086035 Vaccines for therapy of immunomodulatory or immunoregulatory diseases |
| 07/04/2002 | US20020086034 Compositions and methods for treating viral infections |
| 07/04/2002 | US20020086033 Pestivirus mutants and vaccines containing the same |
| 07/04/2002 | US20020086030 Preparations and methods for the treatment of t cell mediated diseases |
| 07/04/2002 | US20020086028 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020086018 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3, and TACI |
| 07/04/2002 | US20020086017 GA binding protein and neurite derived growth factors for use in the treatment of muscular dystrophy |
| 07/04/2002 | US20020086011 Administering an effective amount of an OX-2 protein or a nucleic acid encoding an OX-2 protein; use to suppress an immune response and to prevent or treat autoimmune disease, especially arthritis. |
| 07/04/2002 | US20020086009 Anti-phosphorylated tau protein antibodies and methods for detecting alzheimer`s disease with the use of the same |
| 07/04/2002 | US20020086007 Angiogenesis-inhibiting peptides and proteins and methods of use |
| 07/04/2002 | US20020086004 Especially wherein said angiogenic factor is an endothelial cell growth factor chosen from the FGF family of growth factors and the VEGF family of growth factors. |
| 07/04/2002 | US20020085999 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 07/04/2002 | US20020085998 Breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, and T cells that are specific for cells expressing such polypeptides. |
| 07/04/2002 | US20020085997 Tumor cells at least some of which contain at least one MHC-I-haplotype of the patient on the cell surface, and which are charged with one or more peptides binding to the MHC-I molecule |
| 07/04/2002 | US20020085992 Method for treating inflammation |
| 07/04/2002 | US20020083710 Molecular motor |
| 07/04/2002 | DE10138528A1 Proteasen endogener Retroviren, Substrate davon und Verfahren zum Screenen von Inhibitoren Proteases endogenous retroviruses, substrates thereof, and methods for screening inhibitors |
| 07/04/2002 | DE10065504A1 Adenoviral nucleic acid useful for preventing or treating malignant or benign tumors, by inducing cell lysis, comprises a sequence for the YB-1 protein |
| 07/04/2002 | DE10037759A1 Screeningverfahren Screening method |
| 07/04/2002 | CA2847458A1 Defects in periaxin associated with myelinopathies |
| 07/04/2002 | CA2782510A1 Polypeptides |
| 07/04/2002 | CA2433171A1 Human fgf23 protein mutants decreasing blood phosphorus level |
| 07/04/2002 | CA2432977A1 New use of artemin, a member of the gdnf ligand family |
| 07/04/2002 | CA2432943A1 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
| 07/04/2002 | CA2432927A1 Antibacterial treatments |
| 07/04/2002 | CA2432715A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | CA2432683A1 Screening method based on siah-numb interaction |
| 07/04/2002 | CA2432591A1 A novel human leucine-rich repeat containing protein expressed predominately in bone marrow, hlrrbm1 |
| 07/04/2002 | CA2432380A1 Sugar beet genes involved in stress tolerance |
| 07/04/2002 | CA2432327A1 Screening method based on tsap6 binding partners |
| 07/04/2002 | CA2432214A1 Gene involved in apoptosis regulation |
| 07/04/2002 | CA2431916A1 New therapeutic uses of smr1 peptides |
| 07/04/2002 | CA2431913A1 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | CA2431478A1 Synovial cell protein |
| 07/04/2002 | CA2430930A1 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | CA2430610A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 07/04/2002 | CA2399280A1 Defects in periaxin associated with myelinopathies |
| 07/03/2002 | EP1219712A1 Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium |
| 07/03/2002 | EP1219711A2 Lawsonia intracellularis vaccine |
| 07/03/2002 | EP1219710A1 Novel polypeptides and genes encoding the same |
| 07/03/2002 | EP1219659A1 Amphipathic compound having dendritic structure |
| 07/03/2002 | EP1219639A1 Materials for extracorporeal circulation, adsorbents for diabetic complication factors, containers for eliminating diabetic complication factors and method of eliminating diabetic complication factors |
| 07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
| 07/03/2002 | EP1219637A1 Polypeptides having a triggering NK activity and biological applications |
| 07/03/2002 | EP1219636A2 Modified muteins of erythropoietin (EPO) derived from in vitro or in vivo expression system of microorganisms |
| 07/03/2002 | EP1219635A2 Chlamydia pneumoniae antigenes |
| 07/03/2002 | EP1219303A1 Chondrogenesis promoters |
| 07/03/2002 | EP1219301A1 Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins |
| 07/03/2002 | EP1219299A1 Allergy vaccines and their preparation |
| 07/03/2002 | EP1218751A2 Diagnosis of coeliac disease using a gliadin epitope |
| 07/03/2002 | EP1218747A1 Method for identifying compounds useful in the therapy of bone disorders |
| 07/03/2002 | EP1218538A2 Cancer associated antigens and uses therefor |
| 07/03/2002 | EP1218531A2 Method for extracting bacterio-rhodopsin |
| 07/03/2002 | EP1218526A2 Method for isolating in vitro differentiated somatic cells |
| 07/03/2002 | EP1218525A1 Utrophin gene promoter |
| 07/03/2002 | EP1218521A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 07/03/2002 | EP1218515A2 Regulation with binding cassette transporter protein abc1 |
| 07/03/2002 | EP1218514A1 Designing immunogens |
| 07/03/2002 | EP1218513A2 Lepidopteran-active bacillus thuringiensis delta-endotoxin compositions and methods of use |
| 07/03/2002 | EP1218512A2 Nucleotide sequences of moraxella catarrhalis genome |
| 07/03/2002 | EP1218511A1 Antimicrobial compositions |
| 07/03/2002 | EP1218510A1 Plant seed endosperm-specific promoter |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218506A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218505A2 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218504A2 Gl50 molecules and uses therefor |
| 07/03/2002 | EP1218503A2 Fatty acid transport proteins |
| 07/03/2002 | EP1218502A2 Nicotinic acetylcholine receptor : alpha10 subunit |
| 07/03/2002 | EP1218501A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
| 07/03/2002 | EP1218499A2 RESCUE OF MUMPS VIRUS FROM cDNA |
| 07/03/2002 | EP1218496A2 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 07/03/2002 | EP1218494A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 07/03/2002 | EP1218491A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
| 07/03/2002 | EP1218411A2 Secreted proteins and uses thereof |
| 07/03/2002 | EP1218410A1 Process for obtaining growth factor preparations (tgf-beta and igf-1) from milk products having low mutual cross-contamination |
| 07/03/2002 | EP1218409A2 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 07/03/2002 | EP1218408A1 32 human secreted proteins |